Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Benchtop Instrument Automates Cell Counting

By LabMedica International staff writers
Posted on 22 Oct 2008
A benchtop instrument offers a new method of automated cell counting to replace manual cell counting using a glass hemocytometer.

Called the Countess automated cell counter, the instrument uses only 10 µl of sample, counts live and dead cells, calculates percent viability, measures average cell size, and calculates dilutions for downstream applications.

Currently, scientists use a glass slide with a grid pattern, count cells one by one, add the number of cells in each box and multiply that number by a dilution factor to calculate the final concentration of cells. More...
The Countess automates this process, completing all counts and calculations in approximately 30 seconds.

The Countess cell counter was launched by Invitrogen Corp. (Carlsbad, CA, USA), a provider of essential life science technologies for diagnostics, production, and research. "This instrument was designed with the scientists' workflows in mind, and adds to Invitrogen's already productive line of benchtop instruments, as well as the full line of reagents to support those instruments,” said August Sick, general manager and vice president of Invitrogen's Cellular Analysis Business Unit. "The Countess automates a very tedious and subjective manual process and gives accurate, repeatable results, freeing scientists to concentrate their efforts on the outcomes rather than the process.”

Related Links:
Invitrogen



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.